Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Ctt Pharmaceutical Holdings Q3 2026 Results: Net Loss of $127K, Loss Widens

CTT Pharmaceutical Holdings, Inc. remains a pre-revenue company focused on drug delivery systems, reporting a net loss of $127,064 for the quarter ended September 30, 2026. The company faces a working capital deficit and substantial doubt regarding its ability to continue as a going concern, relying on share issuances and related-party advances to fund operations.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-0.1-0.0
EPS (diluted, $ a share)$-0.00$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Ctt Pharmaceutical Holdings, Inc.: key numbers

Share price
$0.0559Close, Nov 16
Market cap
$3.34M
Shares outstanding
59.72MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Ctt Pharmaceutical Holdings, Inc.

All →
1:05 PM ET 8-K
Other 8-K Filing

Ctt Pharmaceutical Holdings Other 8-K Filing

CTT Pharmaceutical Holdings, Inc. has appointed Zhanna Kelley, CPA as its new PCAOB Auditor effective October 27, 2026. This follows the resignation of the company's previous auditor, Holt & Patterson, which was not due to any disagreements regarding accounting practices.

Counterparty
Zhanna Kelley, CPA
6:01 AM ET 8-K
Leadership Change

Ctt Pharmaceutical Holdings Leadership Change

CTT Pharmaceutical Holdings, Inc. has appointed Karen Larson as an Independent Board Member. Mrs. Larson brings extensive experience as a Certified Financial Planner and former investment banker at Chase Manhattan Bank, as well as entrepreneurial experience from founding a business sold to Morningstar.

Counterparty
Karen Larson

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.